GLOBEFLEX CAPITAL L P - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 161 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLOBEFLEX CAPITAL L P ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2017$32,000
-97.6%
3,341
-97.9%
0.01%
-97.6%
Q4 2016$1,348,000
+134700.0%
156,009
+140448.6%
0.34%
Q3 2016$1,0001110.00%
Other shareholders
PROGENICS PHARMACEUTICALS IN shareholders Q1 2017
NameSharesValueWeighting ↓
EVERENCE CAPITAL MANAGEMENT INC 28,980$123,0000.01%
Daiwa Securities Group Inc. 533$2,0000.00%
IFP Advisors, Inc 0$00.00%
NEW YORK STATE TEACHERS RETIREMENT SYSTEM 138,663$52,0000.00%
View complete list of PROGENICS PHARMACEUTICALS IN shareholders